38 Recruiting Studies Using Avelumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Avelumab
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
š Mayo Clinic Hospital in Arizona ā Phoenix, Arizona
Advanced Bladder Urothelial Carcinoma
View Study & Checklist āA Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Thymoma
View Study & Checklist āA Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study
š University of Miami Sylvester Comprehensive Cancer Center ā Miami, Florida
Breast Cancer Metastatic
View Study & Checklist āA Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
š Beacon Cancer Care ā Coeur d'Alene, Idaho
Locally Advanced or Metastatic Urothelial Carcinoma
View Study & Checklist āAvelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
š M D Anderson Cancer Center ā Houston, Texas
Metastatic Malignant Solid Neoplasm
View Study & Checklist āNeoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer
š University of Alabama at Birmingham ā Birmingham, Alabama
Breast Cancer
View Study & Checklist āTrying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
š Anchorage Associates in Radiation Medicine ā Anchorage, Alaska
Locally Advanced Bladder Urothelial Carcinoma
View Study & Checklist āPemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer
š M D Anderson Cancer Center ā Houston, Texas
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
View Study & Checklist āAvelumab Program Rollover Study
š HonorHealth Research Institute ā Scottsdale, Arizona
Solid Tumors
View Study & Checklist āStudy of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma
š Memorial Sloan Kettering Basking Ridge (All Protocol Activities) ā Basking Ridge, New Jersey
Merkel Cell Carcinoma
View Study & Checklist āStudy BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
š Rocky Mountain Cancer Center ā Denver, Colorado
Metastatic Urothelial Cancer
View Study & Checklist āAvelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
š O'Neal Comprehensive Cancer Center ā Birmingham, Alabama
Stage III Breast Cancer
View Study & Checklist āAvelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma
š Stephenson Cancer Center ā Oklahoma City, Oklahoma
Urothelial Carcinoma
View Study & Checklist āShort-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
š Los Angeles General Medical Center ā Los Angeles, California
Advanced Malignant Skin Neoplasm
View Study & Checklist āThe AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
š University of Alabama at Birmingham ā Birmingham, Alabama
Breast Cancer
View Study & Checklist āAvelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
š University of Chicago ā Chicago, Illinois
Metastatic Endometrial Cancer
View Study & Checklist āStudy of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)
š Providence Medical Foundation ā Santa Rosa, California
Metastatic or Locally Advanced Unresectable Solid Tumors
View Study & Checklist āTesting the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial
š UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care ā Irvine, California
Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
View Study & Checklist āA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
š Exelixis Clinical Site #6 ā Duarte, California
Neoplasm Malignant
View Study & Checklist āPalbociclib After CDK and Endocrine Therapy (PACE)
š University of Miami ā Miami, Florida
Metastatic Breast Cancer
View Study & Checklist āContinued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
š Highlands Oncology Group, PA ā Fayetteville, Arkansas
Advanced Malignancies
View Study & Checklist āAvelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
š M D Anderson Cancer Center ā Houston, Texas
Advanced Malignant Solid Neoplasm
View Study & Checklist āAvelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer
š University of Alabama at Birmingham Cancer Center ā Birmingham, Alabama
Skin Squamous Cell Carcinoma
View Study & Checklist āAvelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
š UC San Diego Moores Cancer Center ā La Jolla, California
Head and Neck Squamous Cell Carcinoma
View Study & Checklist āA Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
š Princess Margaret Cancer Centre ā Toronto, Ontario
Penile Cancer
View Study & Checklist āTesting the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
š City of Hope Comprehensive Cancer Center ā Duarte, California
Locally Advanced Malignant Solid Neoplasm
View Study & Checklist āTrial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma
š University of Rochester Medical Center ā Rochester, New York
Metastatic Pancreatic Adenocarcinoma
View Study & Checklist āTALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
š MedStar Georgetown University Hospital ā Washington D.C., District of Columbia
Breast Cancer
View Study & Checklist āOncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
š Memorial Sloan Kettering Cancer Center ā New York, New York
Melanoma
View Study & Checklist āImmune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
š Emory University Hospital/Winship Cancer Institute ā Atlanta, Georgia
Locally Advanced Bladder Urothelial Carcinoma
View Study & Checklist āAdjuvant Avelumab in Merkel Cell Cancer
š University of California Irvine Chao Family Comprehensive Cancer Center ā Orange, California
Stage III Merkel Cell Carcinoma AJCC v8
View Study & Checklist āPhase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
š Mayo Clinic ā Jacksonville, Florida
HPV-Related Carcinoma
View Study & Checklist āStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2RĪ± Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
š Sylvester Comprehensive Cancer Center - Miami ā Miami, Florida
Advanced Solid Tumor
View Study & Checklist āAvelumab and M1774 in ARID1A-mutated Endometrial Cancer
š Dana-Farber Cancer Institute ā Boston, Massachusetts
Endometrial Cancer
View Study & Checklist āAvelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
š Georgetown University ā Washington D.C., District of Columbia
Breast Cancer
View Study & Checklist āStudy of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
š The University of Arizona Cancer Center-North Campus ā Tucson, Arizona
Metastatic Urothelial Cancer
View Study & Checklist āLurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Small Cell Carcinoma of the Bladder
View Study & Checklist āTesting the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
š University of Alabama at Birmingham Cancer Center ā Birmingham, Alabama
Metastatic Renal Cell Carcinoma
View Study & Checklist ā